1-4 of 4
Javier Briones, MD PhD
Close
Sort by
Journal Articles

Real-World Evidence of Tisagenlecleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Gloria Iacoboni, MD, Josu Iraola-Truchuelo, Nuria Martinez-Cibrian, MD, Rebeca Bailén, MD, Lucia Lopez Corral, PhD MD, Jose M. Sanchez, MD, Manuel Guerreiro, MD, ANA Carolina Carolina CABALLERO González, Alberto Mussetti, MD, Juan-Manuel Sancho, MD PhD, Rafael Hernani, MD, Carlos Solano, MD PhD, Anna Sureda Balari, MD PhD, Javier Briones, MD PhD, Alejandro Martin Garcia-Sancho, MD PhD, Mi Kwon, MD PhD, Juan Luis Reguera, MD PhD, Pere Barba, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–21.
https://doi.org/10.1182/blood-2020-136201
Published: 2020
Journal Articles

Evolution of Outcome over Time for Relapsed Hodgkin Lymphoma after Autologous Stem Cell Transplant: Improved Survival for Early Relapse in Recent Years

Ali Bazarbachi, MD PhD, Ariane Boumendil, Sr., PhD, Hervé Finel, Sr., MD PhD, Irma Khvedelidze, Joanna Romejko-Jarosinska, Alina Daniela Tanase, MDPhD, Saad Akhtar, MD, Tarek Ben Othman, Abdelghani Tbakhi, MD, Boris Afanasyev, MD PhD, Javier Briones, MD PhD, Zafer Gülbas, MD, Jean Elcheikh, MD, Rose-Marie Hamladji, MD PhD, Tugrul Elverdi, MD, Didier Blaise, MD, Carmen Martinez, MD PhD, Eleonora Alma, Kazimierz Halaburda, MD PhD, Aida Botelho de Sousa, Bertram Glass, Stephen Robinson, Silvia Montoto, MD, Anna Sureda Balari, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-138546
Published: 2020
Journal Articles

CAR-T Cells with High CAR Expression Intensity Have Improved I n Vitro and I n Vivo Anti-Lymphoma Effect without Functional Exhaustion

ANA Carolina Carolina CABALLERO González, Laura Escribà-García, PhD, Paula Pujol-Fernández, Eva Escudero-López, Rosanna Montserrat, Cristina Ujaldón-Miró, Jorge Sierra, MD, Carmen Alvarez-Fernández, PhD, Javier Briones, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34.
https://doi.org/10.1182/blood-2020-139546
Published: 2020
Journal Articles

Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma: Primary Analysis of the Full Efficacy Population in a Phase Ib/II Trial

Catherine Diefenbach, MD, Brad S. Kahl, MD, Lalita Banerjee, FRCPath, Andrew K McMillan, FRCP, Fiona Miall, MD FRCPath, MRCP, BMBS, Javier Briones, MD PhD, Raul Cordoba, MD PhD, Jamie Hirata, PharmD, YiMeng Chang, MSc, Lisa Musick, PharmD, Pau Abrisqueta, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 126.
https://doi.org/10.1182/blood-2019-123669
Published: 2019